Financial statements Hyperpharm Dorota Regosz
Balance sheet data of HYPERPHARM DOROTA REGOSZ
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 1 864 190,73 | 2 927 483,57 | 3 665 326,66 | 5 421 696,37 | 5 353 693,36 | 6 688 327,81 |
| A. Fixed assets | 0,00 | 968 274,07 | 973 331,83 | 2 463 290,95 | 1 899 564,56 | 2 289 396,55 |
| B. Current assets | 1 864 190,73 | 1 959 209,50 | 2 691 994,83 | 2 958 405,42 | 3 454 128,80 | 4 398 931,26 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 1 864 190,73 | 2 927 483,57 | 3 665 326,66 | 5 421 696,37 | 5 353 693,36 | 6 688 327,81 |
| A. Equity | 730 277,11 | 1 269 038,14 | 2 596 199,64 | 3 231 270,57 | 4 709 914,94 | 4 997 275,95 |
| B. Liabilities and provisions for liabilities | 1 133 913,62 | 1 658 445,43 | 1 069 127,02 | 2 190 425,80 | 643 778,42 | 1 691 051,86 |
| I. Long-term liabilities | 0,00 | 0,00 | 525 000,00 | 207 812,50 | 76 562,50 | 1 195 905,72 |
| II. Short-term liabilities | 1 133 913,62 | 1 658 445,43 | 544 127,02 | 1 982 613,30 | 567 215,92 | 495 146,14 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.